Pipeline operator Enbridge Inc. agreed to buy three natural gas utilities from Dominion Energy Inc. for US$14 billion.
Pot Stocks See Best Week Since 2020 on Call to Lower Marijuana Risk CategorySEC Delays Decisions on Invesco, WisdomTree Bitcoin ETF FilingsGrayscale Ruling Not Enough to Halt Bitcoin’s Two-Month Losing StreakCash-Like ETFs Lure Billions as Traders Shelter From VolatilityActive ETFs Cash In on Corporate Reform in JapanGutsy
Tesla ETF Wants to Time Bets on Famously Volatile SharesMarks & Spencer Makes a Return to the FTSE 100 as Hiscox Loses Out in ReshuffleThe World’s Biggest Bitcoin Fund Posts Best Day in Two Years on Court RulingUS Court Paves Way for First Bitcoin ETF in Grayscale RulingBitcoin, Crypto Stocks Jump After US Court Paves Way for ETF
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Enbridge to purchase three U.S. utilities for $14 billion in cash and debtCALGARY — Enbridge Inc. says it has signed a US$14 billion cash-and-debt deal to purchase three U.S.-based utility companies. The Calgary-based energy infrastructure giant says the three utilities, owned by Dominion Energy, Inc.
Read more »
Meta Will End Facebook News Service in Europe’s Biggest MarketsMeta Platforms Inc. plans to stop promoting news content for people in three major European countries, the latest sign that the social network giant is trying to leave the industry behind.
Read more »
Meta to end Facebook news service in Europe's biggest marketsMeta Platforms Inc. plans to stop promoting news content for people in three major European countries: U.K., Germany and France. Read on.
Read more »
CME Restarts T-Bill Futures in Response to Demand to Hedge RisksCME Group Inc. will once again offer futures tied to three-month Treasury bills amid growing demand to hedge risks from surging supply and higher short-term interest rates.
Read more »
Genmab, Seagen say Tivdak cervical cancer trial met overall survival endpoint(Reuters) - Genmab A/S and Seagen Inc on Monday said that the Phase III trial of Tivdak in recurrent or metastatic cervical cancer patients on or ...
Read more »